MedPath

Investigating potential biomarkers in Myalgic Encephalomyelitis Chronic Fatigue Syndrome (MECFS) patients

Not Applicable
Conditions
A diagnosis of Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
Registration Number
ACTRN12620001150932
Lead Sponsor
South Australian Health & Medical Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Participants will have a diagnosis of ME/CFS. They will be based in South Australia unless special arrangements can be organised to collect bloods interstate. A formal diagnosis of ME/CFS will have been made by a general practitioner or medical specialist. They will also consent for their GP to be provided with information if required for example feedback about clinical levels of moderate to severe depression. Healthy participants will be those who do not have other current physical health or mental health problems. They will also consent for their GP to be provided with information if required for example feedback about clinical levels of moderate to severe depression.

Exclusion Criteria

Exclusion criterion includes hormonal disorders, major physical or mental health disorders, or outside of the age range. Exclusion criteria include pregnancy, other diseases requiring medication that may affect the results, alcohol or substance abuse or dependence. Other physical disorders that may confound the measurements listed earlier, such as anaemia, or a thyroid disorder. Any mental health disorder that requires medication, psychosis, affective disorders. Low dosages of antidepressant for the purpose of sleep will be accepted. Being unable to understand the consent process due to language or an inability to read English. Must be at least 18 years of age, and up to 65 years.
Morbid Obesity will be an exclusion factor i.e. must have a BMI <40 (35 equates to the WHO obesity type ii and 40 morbidly obese).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath